Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs).
D000085:Acetates / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005017:Ethyl Biscoumacetate / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008722:Methods; D010653:Phenylbutazone / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D013924:Thrombophlebitis / Q000188:drug therapy; D014859:Warfarin / Q000494:pharmacology
D000085:Acetates; D000893:Anti-Inflammatory Agents; D003374:Coumarins; D011720:Pyrazoles; D005017:Ethyl Biscoumacetate; D014859:Warfarin; D000244:Adenosine Diphosphate; D003094:Collagen; D010653:Phenylbutazone